dual glp 1 and gip receptor agonist examples Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Emerging Role of Dual GLP-1
Description
Santo MA, Riccioppo D, Pajecki D, Kawamoto F, de Cleva R, Antonangelo L, Maral L, Cecconello I
Novo Nordisk has not said, Eli Lilly has not said
2019;30(987996):e986
These findings suggest that chronic GLP-1RA treatment may exert anxiolytic and antidepressant effects through modulation of serotonergic pathways and long-term neuroadaptive processes
GLP-1RA reduces cardiovascular risk in T2D patients but may affect thyroid hormone needs
